Media-OutReach Newswire Ocumension Therapeutics: Annual Results Announcement For The Year Ended December 31, 2020
Media-OutReach Newswire Uni-Bio Science Group and DotBio Announce Partnership to Co-Develop multi-specific DotBodies for people with retinal diseases
Media-OutReach Newswire Voluntary Announcement: IND Approval Received for A Phase III Clinical Trial of OT-101 in the United States
Media-OutReach Newswire DHL air freight station in Singapore successfully renews IATA CEIV Pharma certification